updated 3/9/2011 4:18:26 PM ET 2011-03-09T21:18:26

BEIJING, March 9, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that the Company plans to release fourth quarter and full year 2010 financial results on Wednesday, March 16, 2011, after market close.

The Company will hold a conference call at 8:00 am ET on Thursday, March 17, 2011 to discuss fourth quarter and full year 2010 results. Listeners may access the call by dialing:

United States toll free: 1-866-519-4004
China toll free:  400-6208038
Hong Kong toll free:  800-930346
United Kingdom toll free: 0808-2346646
International: 1-718-354-1231
Passcode: 50742371

A telephone replay will be available beginning two hours after the conclusion of the call and will be available through March 31, 2011. Listeners may access the replay by dialing:

United States toll free:  1-866-214-5335
International:  1-718-354-1232
Passcode: 50742371

A webcast will also be available through the Company's website www.nkbp.com.

About China Nuokang Bio-Pharmaceutical Inc.

China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading biopharmaceutical company in China focused on the research, development, manufacture, marketing and sales of hospital-based medical products. The Company provides a diversified portfolio of products across more than 2,400 hospitals in China. Nuokang's principal products include Baquting®, China's leading hemocoagulase product by market share, and Aiduo®, a cardiovascular stress imaging agent. The Company's product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. Please visit www.nkbp.com for more information.

         In the U.S.: Ashley M. Ammon and Christine Duan:
         In China: Wen Lei Zheng:

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com